NEW YORK (GenomeWeb) – Proteomics firm Biognosys said today it has raised $5 million in an extended Series C financing round.

The company said it plans to use the funds to extend its commercial operations, and develop new proteomic workflows and products broadly aimed at the life sciences research market.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.